Du Pont Issues A Recall For Batch Of Anticoagulant

By Ron Wolf, Inquirer Staff Writer
Posted: May 15, 1987

Du Pont Co. issued a nationwide recall yesterday for one batch of its 7.5- milligram Coumadin tablets. The prescription drug is an anticoagulant commonly used to treat heart patients and others at risk from blot clots.

Du Pont said that it detected oversized tablets in one lot of Coumadin numbered YO 244B. If taken, these tablets "would represent a significant overdose" that might result in hemorrhaging, the company warned.

At the same time, the company advised that patients continue taking their prescribed medication.

Retail pharmacists do not normally include lot numbers on the labels of prescriptions they dispense to customers. Du Pont asked patients taking Coumadin in the 7.5-milligram dosage to return unused tablets to their pharmacists for examination and possible replacement.

The round, pale-yellow tablets are stamped Du Pont on one side and 7.5 on the other. The recall does not affect Coumadin in the more common 2.5- and 5- milligram doses.

Since March 19, Du Pont has shipped about 600,000 of the tablets in the

suspect lot from its pharmaceutical plant in Garden City, N.Y. Prescriptions purchased before that date come from lots not subject to the recall, Du Pont said.

Du Pont has established a toll-free hot line, 1-800-443-2261, open from 8 a.m. to 4:30 p.m. weekdays, for patients and pharmacists with questions about the recall.

Index by Keyword
|
Index by Date
|
About Philly.com
|
Contact Us
|
Terms of Use & Privacy Statement
|
Copyright 2013